The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neuropathic Pain Drugs Market Research Report 2025
Synopsis
Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).
The global Neuropathic Pain Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of value, North America is a large market and is expected to increase at over 5% CAGR during the forecast period. The Asia Pacific neuropathic pain management market is projected to show fast growth and it is projected grow at CAGR of 6% over the forecast period due to increasing prevalence of diabetes in Asia Pacific, particularly in China and India.
This report aims to provide a comprehensive presentation of the global market for Neuropathic Pain Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuropathic Pain Drugs.
Report Scope
The Neuropathic Pain Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuropathic Pain Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuropathic Pain Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed
Segment by Type
Tricyclic Anti-Depressants Anticonvulsants
Serotonin-Norepinephrine Reuptake Inhibitor
Capsaicin Cream
Local Anaesthesia
Opioids
Steroids
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuropathic Pain Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).
The global Neuropathic Pain Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of value, North America is a large market and is expected to increase at over 5% CAGR during the forecast period. The Asia Pacific neuropathic pain management market is projected to show fast growth and it is projected grow at CAGR of 6% over the forecast period due to increasing prevalence of diabetes in Asia Pacific, particularly in China and India.
This report aims to provide a comprehensive presentation of the global market for Neuropathic Pain Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuropathic Pain Drugs.
Report Scope
The Neuropathic Pain Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuropathic Pain Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuropathic Pain Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed
Segment by Type
Tricyclic Anti-Depressants Anticonvulsants
Serotonin-Norepinephrine Reuptake Inhibitor
Capsaicin Cream
Local Anaesthesia
Opioids
Steroids
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuropathic Pain Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathic Pain Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tricyclic Anti-Depressants Anticonvulsants
1.2.3 Serotonin-Norepinephrine Reuptake Inhibitor
1.2.4 Capsaicin Cream
1.2.5 Local Anaesthesia
1.2.6 Opioids
1.2.7 Steroids
1.2.8 Others
1.3 Market by Application
1.3.1 Global Neuropathic Pain Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuropathic Pain Drugs Market Perspective (2019-2030)
2.2 Neuropathic Pain Drugs Growth Trends by Region
2.2.1 Global Neuropathic Pain Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neuropathic Pain Drugs Historic Market Size by Region (2019-2024)
2.2.3 Neuropathic Pain Drugs Forecasted Market Size by Region (2025-2030)
2.3 Neuropathic Pain Drugs Market Dynamics
2.3.1 Neuropathic Pain Drugs Industry Trends
2.3.2 Neuropathic Pain Drugs Market Drivers
2.3.3 Neuropathic Pain Drugs Market Challenges
2.3.4 Neuropathic Pain Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuropathic Pain Drugs Players by Revenue
3.1.1 Global Top Neuropathic Pain Drugs Players by Revenue (2019-2024)
3.1.2 Global Neuropathic Pain Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Neuropathic Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuropathic Pain Drugs Revenue
3.4 Global Neuropathic Pain Drugs Market Concentration Ratio
3.4.1 Global Neuropathic Pain Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Drugs Revenue in 2023
3.5 Neuropathic Pain Drugs Key Players Head office and Area Served
3.6 Key Players Neuropathic Pain Drugs Product Solution and Service
3.7 Date of Enter into Neuropathic Pain Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropathic Pain Drugs Breakdown Data by Type
4.1 Global Neuropathic Pain Drugs Historic Market Size by Type (2019-2024)
4.2 Global Neuropathic Pain Drugs Forecasted Market Size by Type (2025-2030)
5 Neuropathic Pain Drugs Breakdown Data by Application
5.1 Global Neuropathic Pain Drugs Historic Market Size by Application (2019-2024)
5.2 Global Neuropathic Pain Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neuropathic Pain Drugs Market Size (2019-2030)
6.2 North America Neuropathic Pain Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neuropathic Pain Drugs Market Size by Country (2019-2024)
6.4 North America Neuropathic Pain Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuropathic Pain Drugs Market Size (2019-2030)
7.2 Europe Neuropathic Pain Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neuropathic Pain Drugs Market Size by Country (2019-2024)
7.4 Europe Neuropathic Pain Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Pain Drugs Market Size (2019-2030)
8.2 Asia-Pacific Neuropathic Pain Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neuropathic Pain Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Neuropathic Pain Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuropathic Pain Drugs Market Size (2019-2030)
9.2 Latin America Neuropathic Pain Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neuropathic Pain Drugs Market Size by Country (2019-2024)
9.4 Latin America Neuropathic Pain Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Pain Drugs Market Size (2019-2030)
10.2 Middle East & Africa Neuropathic Pain Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neuropathic Pain Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Neuropathic Pain Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuropathic Pain Drugs Introduction
11.1.4 Pfizer Revenue in Neuropathic Pain Drugs Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Neuropathic Pain Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Neuropathic Pain Drugs Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Neuropathic Pain Drugs Introduction
11.3.4 Sanofi Revenue in Neuropathic Pain Drugs Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Neuropathic Pain Drugs Introduction
11.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Drugs Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Neuropathic Pain Drugs Introduction
11.5.4 Eli Lilly Revenue in Neuropathic Pain Drugs Business (2019-2024)
11.5.5 Eli Lilly Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Neuropathic Pain Drugs Introduction
11.6.4 Bristol-Myers Squibb Revenue in Neuropathic Pain Drugs Business (2019-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Biogen
11.7.1 Biogen Company Detail
11.7.2 Biogen Business Overview
11.7.3 Biogen Neuropathic Pain Drugs Introduction
11.7.4 Biogen Revenue in Neuropathic Pain Drugs Business (2019-2024)
11.7.5 Biogen Recent Development
11.8 Baxter Healthcare
11.8.1 Baxter Healthcare Company Detail
11.8.2 Baxter Healthcare Business Overview
11.8.3 Baxter Healthcare Neuropathic Pain Drugs Introduction
11.8.4 Baxter Healthcare Revenue in Neuropathic Pain Drugs Business (2019-2024)
11.8.5 Baxter Healthcare Recent Development
11.9 Depomed
11.9.1 Depomed Company Detail
11.9.2 Depomed Business Overview
11.9.3 Depomed Neuropathic Pain Drugs Introduction
11.9.4 Depomed Revenue in Neuropathic Pain Drugs Business (2019-2024)
11.9.5 Depomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Neuropathic Pain Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tricyclic Anti-Depressants Anticonvulsants
Table 3. Key Players of Serotonin-Norepinephrine Reuptake Inhibitor
Table 4. Key Players of Capsaicin Cream
Table 5. Key Players of Local Anaesthesia
Table 6. Key Players of Opioids
Table 7. Key Players of Steroids
Table 8. Key Players of Others
Table 9. Global Neuropathic Pain Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Neuropathic Pain Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Neuropathic Pain Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Neuropathic Pain Drugs Market Share by Region (2019-2024)
Table 13. Global Neuropathic Pain Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Neuropathic Pain Drugs Market Share by Region (2025-2030)
Table 15. Neuropathic Pain Drugs Market Trends
Table 16. Neuropathic Pain Drugs Market Drivers
Table 17. Neuropathic Pain Drugs Market Challenges
Table 18. Neuropathic Pain Drugs Market Restraints
Table 19. Global Neuropathic Pain Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Neuropathic Pain Drugs Market Share by Players (2019-2024)
Table 21. Global Top Neuropathic Pain Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Drugs as of 2023)
Table 22. Ranking of Global Top Neuropathic Pain Drugs Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Neuropathic Pain Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Neuropathic Pain Drugs Product Solution and Service
Table 26. Date of Enter into Neuropathic Pain Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neuropathic Pain Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Neuropathic Pain Drugs Revenue Market Share by Type (2019-2024)
Table 30. Global Neuropathic Pain Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Neuropathic Pain Drugs Revenue Market Share by Type (2025-2030)
Table 32. Global Neuropathic Pain Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Neuropathic Pain Drugs Revenue Market Share by Application (2019-2024)
Table 34. Global Neuropathic Pain Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Neuropathic Pain Drugs Revenue Market Share by Application (2025-2030)
Table 36. North America Neuropathic Pain Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Neuropathic Pain Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Neuropathic Pain Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Neuropathic Pain Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Neuropathic Pain Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Neuropathic Pain Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Neuropathic Pain Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Neuropathic Pain Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Neuropathic Pain Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Neuropathic Pain Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Neuropathic Pain Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Neuropathic Pain Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Neuropathic Pain Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Neuropathic Pain Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Neuropathic Pain Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Neuropathic Pain Drugs Product
Table 54. Pfizer Revenue in Neuropathic Pain Drugs Business (2019-2024) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Neuropathic Pain Drugs Product
Table 59. Johnson & Johnson Revenue in Neuropathic Pain Drugs Business (2019-2024) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Sanofi Company Detail
Table 62. Sanofi Business Overview
Table 63. Sanofi Neuropathic Pain Drugs Product
Table 64. Sanofi Revenue in Neuropathic Pain Drugs Business (2019-2024) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Neuropathic Pain Drugs Product
Table 69. GlaxoSmithKline Revenue in Neuropathic Pain Drugs Business (2019-2024) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Eli Lilly Company Detail
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Neuropathic Pain Drugs Product
Table 74. Eli Lilly Revenue in Neuropathic Pain Drugs Business (2019-2024) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. Bristol-Myers Squibb Company Detail
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb Neuropathic Pain Drugs Product
Table 79. Bristol-Myers Squibb Revenue in Neuropathic Pain Drugs Business (2019-2024) & (US$ Million)
Table 80. Bristol-Myers Squibb Recent Development
Table 81. Biogen Company Detail
Table 82. Biogen Business Overview
Table 83. Biogen Neuropathic Pain Drugs Product
Table 84. Biogen Revenue in Neuropathic Pain Drugs Business (2019-2024) & (US$ Million)
Table 85. Biogen Recent Development
Table 86. Baxter Healthcare Company Detail
Table 87. Baxter Healthcare Business Overview
Table 88. Baxter Healthcare Neuropathic Pain Drugs Product
Table 89. Baxter Healthcare Revenue in Neuropathic Pain Drugs Business (2019-2024) & (US$ Million)
Table 90. Baxter Healthcare Recent Development
Table 91. Depomed Company Detail
Table 92. Depomed Business Overview
Table 93. Depomed Neuropathic Pain Drugs Product
Table 94. Depomed Revenue in Neuropathic Pain Drugs Business (2019-2024) & (US$ Million)
Table 95. Depomed Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuropathic Pain Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Neuropathic Pain Drugs Market Share by Type: 2023 VS 2030
Figure 3. Tricyclic Anti-Depressants Anticonvulsants Features
Figure 4. Serotonin-Norepinephrine Reuptake Inhibitor Features
Figure 5. Capsaicin Cream Features
Figure 6. Local Anaesthesia Features
Figure 7. Opioids Features
Figure 8. Steroids Features
Figure 9. Others Features
Figure 10. Global Neuropathic Pain Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Neuropathic Pain Drugs Market Share by Application: 2023 VS 2030
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Online Pharmacies Case Studies
Figure 15. Neuropathic Pain Drugs Report Years Considered
Figure 16. Global Neuropathic Pain Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Neuropathic Pain Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Neuropathic Pain Drugs Market Share by Region: 2023 VS 2030
Figure 19. Global Neuropathic Pain Drugs Market Share by Players in 2023
Figure 20. Global Top Neuropathic Pain Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Drugs as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Neuropathic Pain Drugs Revenue in 2023
Figure 22. North America Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Neuropathic Pain Drugs Market Share by Country (2019-2030)
Figure 24. United States Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Neuropathic Pain Drugs Market Share by Country (2019-2030)
Figure 28. Germany Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Neuropathic Pain Drugs Market Share by Region (2019-2030)
Figure 36. China Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Neuropathic Pain Drugs Market Share by Country (2019-2030)
Figure 44. Mexico Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Neuropathic Pain Drugs Market Share by Country (2019-2030)
Figure 48. Turkey Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Neuropathic Pain Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Pfizer Revenue Growth Rate in Neuropathic Pain Drugs Business (2019-2024)
Figure 51. Johnson & Johnson Revenue Growth Rate in Neuropathic Pain Drugs Business (2019-2024)
Figure 52. Sanofi Revenue Growth Rate in Neuropathic Pain Drugs Business (2019-2024)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Drugs Business (2019-2024)
Figure 54. Eli Lilly Revenue Growth Rate in Neuropathic Pain Drugs Business (2019-2024)
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Neuropathic Pain Drugs Business (2019-2024)
Figure 56. Biogen Revenue Growth Rate in Neuropathic Pain Drugs Business (2019-2024)
Figure 57. Baxter Healthcare Revenue Growth Rate in Neuropathic Pain Drugs Business (2019-2024)
Figure 58. Depomed Revenue Growth Rate in Neuropathic Pain Drugs Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
